Henry Schein One integrates Align Technology iTero scanners into Dentrix platforms. Discover what this shift means for digital dentistry workflows and adoption.
SABCS data suggests endocrine activity may predict who truly benefits from extended endocrine therapy. Here is what Delphi Diagnostics’ findings mean.
FDA clears Explant Express for ruptured breast implant removal. Explore what this means for surgical workflows, adoption risks, and explantation standardisation.
Diamond Lake Clinic introduces EXOMIND for depression care. Find out what this shift means for neuromodulation, evidence standards, and mental health treatment models.
StimLabs has secured FDA clearance for DermaForm, expanding its wound care portfolio. Find out what this changes for clinicians and the market.
New England Biolabs launches an automation-ready cfDNA extraction kit. Find out what this changes for liquid biopsy workflows and diagnostics development.
Randomized trial data show the FDA-cleared IpsiHand brain-computer interface improved chronic stroke recovery. Find out what this changes for rehab care.
Medtronic wins FDA clearance for Stealth AXiS in spine robotics. Explore what this integrated platform means for workflow, data, and adoption.
WHOOP launches Advanced Labs in the UAE with Unilabs, integrating 65 biomarkers into its wearable platform. Explore what this shift means.
Kirin and Immunosens are developing a urinary IgA self-testing service to visualize immune status. Find out what this changes for consumer immune monitoring.